Cointime

Sagard Healthcare Royalty Partners

investment firm

About

Sagard Healthcare Royalty Partners is the royalty investment unit of private-equity firm of Sagard Holdings.

Highlights

Investments
3
Lead Investments
2
Exits
3

Details

Operating Status
Active
Investor Type
PE

Funds Raised

Announced Date Fund Name Money Raised
Jan 10, 2020 Fund I $475M

Investments

Number of Investments
Number of Lead Investments
3
2
Sagard Healthcare Royalty Partners has made 3 investments. Their most recent investment was on Nov 1, 2022, when Phathom Pharmaceuticals raised $40M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 1, 2022 Phathom Pharmaceuticals
Post-IPO Debt $40M Biotechnology —
Oct 31, 2022 Marinus Pharmaceuticals
Post-IPO Debt $32.50M Biopharma Yes
Aug 2, 2022 Valeo Pharma
Post-IPO Debt $40M Biotechnology Yes

Exits

Sagard Healthcare Royalty Partners has had 3 exits. Sagard Healthcare Royalty Partners most notable exits include Phathom Pharmaceuticals ,   Valeo Pharma

Date Company Name Exit Type Industry
Oct 24, 2019 Phathom Pharmaceuticals IPO Biotechnology Detail
Feb 22, 2019 Valeo Pharma IPO Biotechnology Detail
Jul 21, 2014 Marinus Pharmaceuticals IPO Biopharma Detail
Cointime
เนื้อหา
บริษัท